- Filed
- Oct 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 28, 2025 | 29.54M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 29.86M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 30.04M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 30.75M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 30.79M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $63.74M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $10.94M |
| Capex | Q3 2025 · Sep 30, 2025 | $37.18M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $11.51M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $131.55M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $154.34M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $89.4M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $269.48M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $951.77M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $1.04B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.05B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $1B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $975.67M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $915M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $387.77M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $254.86M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $695.45M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $651.33M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.44B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.42B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.98 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.40 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $1.11 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $2.96 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.99 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.40 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $1.11 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $2.98 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $42.8M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $132.33M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $38.21M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $122.71M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$89.06M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$41.94M |
| Net Income | Q3 2025 · Sep 30, 2024 | $34.04M |
| Net Income | Q3 2025 · Sep 30, 2024 | $91.18M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $39.94M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $108.1M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $43.17M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $114.09M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $82.75M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $240.43M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $81.38M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $236.8M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $228.19M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $626.38M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $195.75M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $554.97M |
| Revenue | Q3 2025 · Sep 30, 2025 | $310.94M |
| Revenue | Q3 2025 · Sep 30, 2025 | $866.81M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $277.13M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $791.77M |